Atlas Trials

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Clinical trial NCT03287063 · TERMINATED

Trial details

NCT number
NCT03287063
Sponsor
University of Michigan Rogel Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
Glioblastoma
Start date
2018-07-05
Primary completion
2020-03-23
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.